Article
The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.
Clinical biochemistry - 1 Jan 2013
Garelnabi Mahdi, Lor Kenton, Jin Jun, Chai Fei, Santanam Nalini
Abstract excerpt
UNLABELLED: Apolipoprotein A5 (ApoA5) is a key regulator of plasma triglycerides (TG), even though its plasma concentration is very low compared to other known apoproteins. Over the years, researchers have attempted to elucidate the molecular mechanisms by which ApoA5 regulates plasma TG in vivo. Though still under debate, two theories broadly describe how ApoA5 modulates TG levels: (i) ApoA5 enhances the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
